Retbindin (RTBDN)

Retbindin (RTBDN) is a retina-specific riboflavin-binding protein, structurally related to riboflavin-binding proteins in other species, but found only in the neural retina of mammals[1][2][3]. It physically localizes to the junction between the neural retina and the retinal pigment epithelium (RPE), where it is believed to facilitate the transport or sequestration of riboflavin (vitamin B2) and its derivatives, critical cofactors in cellular metabolism and redox balance. Retbindin's function is essential for maintaining the high level of flavins (FMN, FAD) necessary for the retina's unique and particularly demanding energy metabolism. Genetic ablation of retbindin in animal models leads to a dramatic reduction in retinal flavins, resulting in metabolic dysfunction, impaired glycolytic flux, increased oxidative stress, progressive rod and cone photoreceptor degeneration, and ultimately loss of retinal function[1][2][3]. The protein is not known to be a drug target, nor are drugs known to interact with it, but its crucial role in retinal health makes it a potential candidate for neuroprotective strategies in inherited retinal degenerations.

Other names

RetbindinRTBDNFLJ36353

not a recognized therapeutic drug target; mechanism is maintenance of flavin homeostasis, not direct drug action